. Cytoplasmic and plasma Gelsolin start sites within the precursor Rattus norvegicus Gelsolin amino acid sequence.
. Cytoplasmic and plasma Gelsolin start sites within the precursor Rattus norvegicus Gelsolin amino acid sequence. Primary cardiomyocytes were infected with gelsolin (GSN) adenoviruses (AdVs) and correct GSN expression was confirmed by western blotting. (A) A C-terminal GSN antibody (Abcam) was used to detect GSN expression. Overexpression of full-length/wild-type (WT) was seen in cardiomyocytes infected with WT GSN at MOI 1 and MOI 10. Processing of GSN occurs at MOI 10. C-terminal GSN overexpression was observed (*). (B) An N-terminal GSN antibody (Santa Cruz) was used to verify N-terminal GSN overexpression in N-terminal GSN infected cardiomyocytes (*). (C) D401A GSN-AdV infected cardiomyocytes were null of GSN processing that was evident in WT infected cardiomyocytes (*).
NoAdV Figure S3 . Green fluorescence levels in no adenovirus treated rat heart.
Heart tissue sections from rats that were infected with a green fluorescence tagged adenovirus (GFP-AdV) (panels a and b) were compared to sections from rats that were not infected with AdVs (panels c and d). GFP levels are shown in green. Q&, 00 10���� GFP-AdV
< Figure S4 . Left ventricular posterior wall thickness and fractional shortening measured throughout gelsolin adenovirus in vivo study. Figure S5 . Additional analysis of heart sections 28 days after Gelsolin Adenovirus infection. (A) Cardiomyocytes were infected with the NFAT-luciferase reporter AdV or activated calcineurin-AdV (MOI=20 each), or with GFP-AdV or the GSN-AdVs (WT, N-terminal, C-terminal, D401A) at MOI=1 each. Significant activation of NFAT was observed upon stimulation with activated Calcineurin at 12 h (n=4; **, P<0.01) and 24 h (n=4; **, P<0.01). However, minimal NFAT activation was observed upon stimulation with GFP control or with WT-GSN and corresponding GSN fragments at 12 and 24 hours. Error bars represent SEM. (B) Primary cardiomyocytes were treated with recombinant human cardiotrophin 1 (hCT1, 0.5 nM) (0-24 hr) and analyzed by immunoblotting using a C-terminal GSN antibody. Cleavage of GSN is attenuated during CT1 stimulation.
